Genalyte
Genalyte, Inc. is a San Diego, California in-vitro diagnostics company building point-of-care blood testing systems based on silicon photonic microring resonator technology. Founded by Cary Gunn, the company developed the Maverick Diagnostic System and its successor Merlin, an automated benchtop analyzer that runs hematology, chemistry and immunoassay panels — including CBC, lipid panel and comprehensive metabolic panel — from small whole-blood or serum volumes and returns results in roughly twenty to thirty minutes while the patient is still in the clinic. A cloud verification layer the company markets as CloudLab quality-checks results and routes them into electronic medical record systems. Genalyte received FDA clearance for a thyroid stimulating hormone immunoassay performed on a silicon chip and previously held an FDA Emergency Use Authorization for a rapid COVID-19 antibody test. The company is investor-backed (Khosla Ventures, Verily Life Sciences and others) and is a HIPAA covered entity that publishes a Notice of Privacy Practices. As of this profile Genalyte publishes no public developer portal, API documentation, or machine-readable API specification.
Genalyte is profiled on the APIs.io network. Tagged areas include Company, Health, Healthcare, Diagnostics, and Medical Devices.
Genalyte’s developer surface includes engineering blog, support, and 14 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 2
Properties that don't map to a standard resource type